Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Madrid, Spain.
Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Adv Wound Care (New Rochelle). 2021 Jun;10(6):301-316. doi: 10.1089/wound.2020.1206. Epub 2020 Aug 7.
Wound healing is a complex process that involves the interaction between different cell types and bioactive factors. Impaired wound healing is characterized by a loss in synchronization of these interactions, resulting in nonhealing chronic wounds. Chronic wounds are a socioeconomic burden, one of the most prominent clinical manifestations of diabetes, however, they lack satisfactory treatment options. The objective of this study was to develop polymeric composites that deliver ions having wound healing properties and evaluate its performance using a pressure ulcer model in diabetic mice. To develop a polymeric composite wound dressing containing ion-releasing nanoparticles for chronic wound healing. This composite was chemically and physically characterized and evaluated using a pressure ulcer wound model in diabetic (db/db) mice to explore their potential as novel wound dressing. This dressing exhibits a controlled ion release and a good bioactivity. The polymeric composite dressing treatment stimulates angiogenesis, collagen synthesis, granulation tissue formation, and accelerates wound closure of ischemic wounds created in diabetic mice. In addition, the performance of the newly designed composite is remarkably better than a commercially available dressing frequently used for the treatment of low-exuding chronic wounds. The developed nanoplatforms are cell- and growth factor free and control the host microenvironment resulting in enhanced wound healing. These nanoplatforms are available by cost-effective synthesis with a defined composition, offering an additional advantage in potential clinical application. Based on the obtained results, these polymeric composites offer an optimum approach for chronic wound healing without adding cells or external biological factors.
伤口愈合是一个复杂的过程,涉及不同细胞类型和生物活性因子的相互作用。伤口愈合受损的特征是这些相互作用失去同步,导致无法愈合的慢性伤口。慢性伤口是一种社会经济负担,是糖尿病最突出的临床表现之一,但缺乏令人满意的治疗选择。本研究的目的是开发具有伤口愈合特性的离子释放聚合物复合材料,并使用糖尿病小鼠的压疮模型评估其性能。 为了开发一种含有离子释放纳米颗粒的聚合物复合伤口敷料,用于慢性伤口愈合。对这种复合材料进行了化学和物理表征,并使用糖尿病(db/db)小鼠的压疮模型进行了评估,以探索其作为新型伤口敷料的潜力。 这种敷料具有可控的离子释放和良好的生物活性。聚合物复合敷料处理可刺激血管生成、胶原合成、肉芽组织形成,并加速糖尿病小鼠缺血性伤口的闭合。此外,新设计的复合材料的性能明显优于常用于治疗低渗出性慢性伤口的市售敷料。 开发的纳米平台不含细胞和生长因子,可控制宿主微环境,从而促进伤口愈合。这些纳米平台可通过具有明确定义组成的具有成本效益的合成获得,为潜在的临床应用提供了额外的优势。 基于获得的结果,这些聚合物复合材料为慢性伤口愈合提供了一种最佳方法,无需添加细胞或外部生物因素。